Showing results (31-40 of 578) with videos related to
Sort By:
Pageof 58
Der Nervenarzt|August 24, 2019
[Prevention of cognitive decline and dementia by treatment of risk factors]Claus Escher, Frank JessenMultiple Sclerosis (Houndmills, Basingstoke, England)|August 28, 2014
Addressing the regulatory and scientific challenges in multiple sclerosis--a statement from the EU regulatorsPavel Balabanov, Manuel Haas, Andre Elferink, et al.Advances in Experimental Medicine and Biology|March 29, 2012
Voltage-gated Ca(2+) channel mediated Ca(2+) influx in epileptogenesisMagdalena Siwek, Christina Henseler, Karl Broich, et al.Scientific Reports|July 8, 2021
Breeding of Cav2.3 deficient mice reveals Mendelian inheritance in contrast to complex inheritance in Cav3.2 null mutant breedingAnna Papazoglou, Christina Henseler, Karl Broich, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 23, 2009
Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort studyUwe Ehrt, Karl Broich, Jan Petter Larsen, et al.Translational Psychiatry|May 21, 2020
Depression-an underrecognized target for prevention of dementia in Alzheimer's diseaseForugh S Dafsari, Frank JessenFortschritte Der Neurologie-Psychiatrie|April 25, 2018
[Late life depression - Diagnosis, pathophysiology and therapeutic strategies]Forugh S Dafsari, Frank JessenNature Reviews. Drug Discovery|July 2, 2010
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectivesHarald Hampel, Richard Frank, Karl Broich, et al.BMC Neurology|September 2, 2018
Hyperuricemia and dementia - a case-control studyBettina Engel, Willy Gomm, Karl Broich, et al.European Archives of Psychiatry and Clinical Neuroscience|May 17, 2005
Risk factors and early signs of Alzheimer's disease in a family study sample. Risk of ADReinhard Heun, Heike Kölsch, Frank JessenPageof 58